CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. 8-K

What Happened

• Creative Medical Technology Holdings, Inc. (CELZ) filed an 8-K disclosing that at a Special Meeting of Stockholders on December 26, 2025, stockholders approved a proposal to permit the exercise in full of warrants to purchase an aggregate of 2,790,340 shares of the company’s common stock.
• Stockholders holding 1,037,465 shares (36.4% of outstanding shares as of the record date) were present in person or by proxy and constituted a quorum. Voting results reported: For — 618,178; Against — 183,985; Abstain — 235,381. Per Nasdaq rules, 220,500 votes “For” cast by holders of the warrants were treated as “Abstain.”

Key Details

• Special Meeting date: December 26, 2025; results disclosed in an 8-K filed December 31, 2025.
• Proposal approved: allow exercise in full of warrants to purchase 2,790,340 common shares (warrants issued October 29, 2025).
• Quorum: 1,037,465 shares represented (36.4% of outstanding).
• Vote tally: For 618,178; Against 183,985; Abstain 235,381 (including 220,500 warrant-holder votes treated as abstentions under Nasdaq rules).

Why It Matters

• The approval enables the exercise of warrants that, if exercised, would result in issuance of up to 2,790,340 additional common shares. That outcome would increase the company’s shares outstanding and could dilute existing shareholders’ ownership percentages.
• The Nasdaq rule treatment of certain warrant-holder votes affected the abstention count and therefore the official vote totals disclosed by the company.